Human studies link plasma glucose with brain age gap and glucose with fragility fractures. A trial reports lower glucose with walking football in adults over 60. Human trials of time-restricted feeding and resveratrol report both glucose reductions and no clear effect, while ketone-drink trials report reductions.
479 findings in 413 papers from 1986 to 2026, 59 of them since April 2026
“Overall, individuals in the high-risk group were at higher risk of progression to T2D.”
Caloric restriction showed no clear effect on glucose in humans (86±7 to 84±11 mg/dl, p=0.33, d=0.3).
“Blood glucose (86±7 to 84±11 mg/dl, p=0.33, d=0.3) and blood lipids (total cholesterol (196±49 to 203±54 mg/dl, p=0.16, d=0.4) and TC/HDL (4.9±2.4 to 6.1±4.7, p=0.13, d=0.4)) were unchanged.”
Caloric restriction decreases glucose in rats (maternal CR during lactation).
“Both groups showed a reduction in serum glucose levels in the offspring, as well as a reduction in the activity of superoxide dismutase (SOD) in the hypothalamus.”
Resveratrol showed no clear effect on glucose in individuals with dyslipidemia.
“Nevertheless, we failed to detect significant differences in glucose, insulin, or oxidative stress biomarkers between the resveratrol groups and placebo.”
Human trialin individuals with dyslipidemia8 weeks
“There were significant differences in changes in blood glucose levels at post-treatment among participants in the moderate and high dose resveratrol groups compared to participants receiving the placebo (p = 0.02 and p = 0.01, respectively) with/without adjustment of the baseline glucose levels.”
Resveratrol decreases glucose in humans (overweight, older adults) (ps<0.05).
“Compared to placebo, glucose levels were significantly lower at post-treatment among participants randomized to both resveratrol conditions, with and without adjustment for the corresponding baseline values (ps<0.05).”
Human trialoverweight, older adultscapsule300mg/day and 1000mg/day90daysn = 32
“Treatment with resveratrol attenuated the increased glucose levels (pre- and post-prandial), impaired glucose tolerance, HbA1c, and decreased the body weights of the T2DM rats.”
“Venous glucose, insulin, and HOMA‐IR were lower after exercise relative to the rest condition (p < 0.001, all); however, there were no differences found for venous lactate concentration between rest and exercise conditions (p = 0.27).”
Diabetes, metabolic syndrome and obesity : targets and therapy·
Exercise decreases glucose in humans (acute studies, pre- to post-exercise) (MD 0.53 mmol/L, 95% CI 0.10 to 0.96).
“afternoon exercise was associated with greater reductions in glucose levels from pre- to post-exercise (MD 0.53 mmol/L, 95% CI 0.10 to 0.96, I2 = 21%, p = 0.02)”
Resistance training increases glucose in humans (5.20±0.63 vs. 5.46±0.51).
“In contrast, the MJ group exhibited a significant increase in triglyceride and fasting plasma glucose (FPG) (1.13±0.35 vs. 1.44±0.44; 5.20±0.63 vs. 5.46±0.51; p = 0.001, p = 0.002, respectively).”
Resistance training showed no clear effect on glucose in humans.
“There were no observed differences in glucose, testosterone, GH, and lactate concentrations both at 2 and 24 h after the execution of the two training methods.”
Resistance training decreases glucose in humans (Overweight/obese postmenopausal and older females; compared with control) (Hedges' g -1.19, 95% CI -1.63 to -0.74).
“HVRT demonstrated higher effect sizes than LVRT for glucose (HVRT = -1.19; 95%CI: -1.63 to -0.74; LVRT = -0.78; 95%CI:-1.15 to -0.41)”
ReviewOverweight/obese postmenopausal and older females; compared with controlhigh-volume resistance training∼77 sets/weekfemales
American journal of physiology. Endocrinology and metabolism·
(r)-3-hydroxybutyl (r)-3-hydroxybutyrate showed no clear effect on glucose in adults with type 2 diabetes.
“There were no differences in the primary outcomes of plasma glucose concentration (acutely) or serum fructosamine (glycemic control across 14 days) between conditions.”
Human trialin adults with type 2 diabetesplasma0.3 g/kg body massacuten = 18
American journal of physiology. Endocrinology and metabolism·
(r)-3-hydroxybutyl (r)-3-hydroxybutyrate decreases glucose in humans (5.00 (1.01) vs 3.56 (0.66) mmol/L).
“post-intervention blood glucose, lactate, and non-esterified fatty acid concentrations were significantly lower than pre-intervention values: mean (SD) = 5.00 (1.01) vs 3.56 (0.66) mmol/L, p ≪ 0.001”
(r)-3-hydroxybutyl (r)-3-hydroxybutyrate decreases glucose in humans (-28.8%, p < 0.001).
“post-intervention blood glucose, lactate and non-esterified fatty acid concentrations decreased significantly (-28.8%, p ≪ 0.001; -28.2%, p = 0.02; and -49.1%, p ≪ 0.001, respectively)”
(r)-3-hydroxybutyl (r)-3-hydroxybutyrate decreases glucose in mice (postexercise, concomitant with glucose).
“The KE-treated group showed significantly lower postadministration blood glucose concentrations and higher plasma insulin concentrations compared with those of the Con-treated group.”
Animalspostexercise, concomitant with glucose2.0 g/kg BWmales
Time-restricted feeding decreases glucose in veterans with spinal cord injury and obesity (-7 ± 3 mg/dL).
“Twenty-four-hour glucose levels decreased by 7 ± 3 mg/dL (p = 0.02) and the GMI decreased by 0.2 ± 0.1% (p = 0.02), both with large effect sizes (d ~0.8).”
Human trialin veterans with spinal cord injury and obesity6-week
Time-restricted feeding decreases glucose in humans during 3-hour OGTT (Δ = − 5.3 ± 14.7 mg/dL vs Δ = 4.9 ± 13.6 mg/dL).
“Mean glucose levels during the OGTT after the glucose bolus, were significantly lower from baseline to post-intervention in EOF (Δ = − 5.3 ± 14.7 mg/dL) compared to the control group (Δ = 4.9 ± 13.6 mg/dL, group × visit p = 0.028,, ).”
Human trialduring 3-hour OGTTaverage duration of 7.5 ± 0.7 weeksn = 39
Time-restricted feeding decreases glucose in high-fat diet-fed flies switched to control diet.
“Flies with metabolic damage that received TRF showed lower total triglyceride content, Nlaz expression, circulating glucose, and weight compared to Ad libitum.”
Model organismsin high-fat diet-fed flies switched to control dietseven days
Intermittent fasting showed no clear effect on glucose in humans (6.1 ± 0.5, 5.7 ± 0.4, and 5.8 ±0.5 mmol/L).
“Blood glucose measurements was performed at 15:30 and showed no significant differences between the three periods (6.1 ± 0.5, 5.7 ± 0.4, and 5.8 ±0.5 mmol/L, respectively).”
Intermittent fasting decreases glucose in rats (maternal IF during lactation).
“Both groups showed a reduction in serum glucose levels in the offspring, as well as a reduction in the activity of superoxide dismutase (SOD) in the hypothalamus.”
“Glucose levels were reduced over the 6-weeks for both KD groups and, despite fluctuations across time points, were unchanged in the LFD group at the end of the study.”
American journal of physiology. Endocrinology and metabolism·
High-intensity interval training increases glucose in individuals with type 1 diabetes (167.48 ± 66.96 mg/dL vs CON 150.43 ± 61.69 mg/dL, P = 0.021).
“Average whole-day glucose levels were higher on the day of HIIT (167.48 ± 66.96 mg/dL; group × time P = 0.021) and MICT (166.46 ± 61.35 mg/dL; group × time P = 0.039) compared with CON”
Human trialin individuals with type 1 diabetesn = 14
High-intensity interval training decreases glucose in humans (5.7 ± 1.3 to 5.3 ± 0.9 mmol/l).
“HIIT produced a small reduction in SED glucose compared to baseline (5.7 ± 1.3 mmol·l−1 at baseline and 5.3 ± 0.9 mmol·l−1 post-HIIT; Cohen's d = 0.36)”
Ketone monoester decreases glucose in humans (22.09 ± 10.43 mg/dL).
“The glucose-suppression magnitude (22.09 ± 10.43 mg/dL) shows that circulating glucose fell by roughly one-fifth of a typical baseline level after KME ingestion, confirming a meaningful but transient hypoglycemic effect.”
“Granger causality analysis confirmed that KME supplementation acutely suppressed ISF glucose, with an initial effect at 5 min and a sustained post-dose suppression phase between 25 and 55 min.”
Low-carbohydrate diet decreases glucose in humans (−18.6 ± 86.2 vs −100.0 ± 57.7 mg/dL).
“The mean difference of 2‐h glucose between the baseline and 18 months was significantly greater in the LCD group than the TDD group (−18.6 ± 86.2 vs −100.0 ± 57.7 mg/dL, P < 0.05; Table ).”
Low-carbohydrate diet showed no clear effect on glucose in humans.
“Fasting glucose, HOMA-IR, total cholesterol, HDL-cholesterol, and LDL cholesterol decreased to the same extent between the three dietary interventions.”
Empagliflozin decreases glucose in scopolamine and heavy metal mixture-induced Alzheimer's disease rats.
“notable suppressive impact of EMPA on lipid peroxidation, acetylcholinesterase, glucose levels, phosphorylated tau protein, pro-inflammatory cytokines, and neuropathological changes”
Animalsin scopolamine and heavy metal mixture-induced Alzheimer's disease ratsmales
Aerobic exercise increases glucose in humans (exercise only compared to dual condition task) (mean increase of 9.5% +/- 16.4%, Cohen's D=0.57).
“Glucose was utilized more in the exercise only task compared to the dual condition task (Visit 2 – Visit 1 difference: mean increase of 9.5% +/- 16.4% in pre-post % change)”
Human trialexercise only compared to dual condition task10-minutesfemalesn = 10
Tirzepatide decreases glucose in humans (compared with dulaglutide).
“Compared with dulaglutide, statistically significant reductions in change from baseline in AUC(0–6h) after dose for glucose, insulin, glucagon, C‐peptide and triglycerides AUC(0–6h) were observed at Week 32 in participants randomized to tirzepatide, except in the case of triglycerides with tirzepatide 10 mg”
Human trialcompared with dulaglutide52 weeksn = 48
Glucose is linked with kidney failure in humans (Mediation of the relationship between body mass index and renal failure) (7.02% mediated).
“five acted as mediators in the relationship between BMI and renal failure: cystatin C (12.34%), glucose (7.02%), glycated hemoglobin (HbA1c) (6.83%), diastolic blood pressure (6.37%)”
HumansMediation of the relationship between body mass index and renal failure
Glucose is linked with lower sleep efficiency in humans (free-living adults with overweight or obesity at risk of type 2 diabetes) (B = -0.05% per 1 mg/dL increase).
“daytime mean glucose was associated with later wake-up time (0.008 [0.002, 0.014] h; p = 0.008), longer sleep period time (0.006 [0.000, 0.012] h; p = 0.039) and lower sleep efficiency (-0.05% [-0.08%, -0.01%] %; p = 0.005)”
Humansfree-living adults with overweight or obesity at risk of type 2 diabetes14 daysn = 388
Age is linked with higher glucose in humans (0.212 <= r <= 0.370, p < 0.05).
“The age increase was positively correlated (0.212 ≤ r ≤ 0.370, p < 0.05) with the clinical markers (total cholesterol, HDL, LDL, VLDL, triacylglyceride, and glucose levels)”
Sleep efficiency is linked with lower glucose in humans (free-living adults with overweight or obesity at risk of type 2 diabetes) (B = -0.05 mg/dL per 1% increase).
“Each 1% increase in sleep efficiency was associated with lower next-day mean glucose (B [95% CI] = -0.05 [-0.08, -0.01] mg/dL; p = 0.007).”
Humansfree-living adults with overweight or obesity at risk of type 2 diabetes14 daysn = 388
Inflammation increases glucose in humans (2–5 h after the WDHC meal).
“The inflammatory state had a meal-dependent effect on glycaemic responses: the high inflammation group had significantly higher postprandial glucose concentrations 2–5 h after the WDHC meal than the low inflammation group (P = 0.006).”
Glucose is associated with hypertension in humans (from the normal state or elevated state).
“Increasing age, body mass index (BMI) and glucose were associated with the probability of developing hypertension from the normal state or elevated state.”
Glucose is linked with a higher risk of dementia in participants without diabetes (adjusted HR 1.18 (95% CI, 1.04 to 1.33)).
“Among participants without diabetes, higher average glucose levels within the preceding 5 years were related to an increased risk of dementia (P=0.01)”
Humansin participants without diabetesmedian follow-up of 6.8 years
Twin research and human genetics : the official journal of the International Society for Twin Studies·
Glucose is linked with a higher risk of mortality in elderly non-diabetic patients hospitalized for pneumonia (aHR 1.3-2.7, p<0.05).
“In elderly non-diabetic patients hospitalized for pneumonia, moderately and markedly elevated ABG is associated with increased short- and long-term mortality.”
Humansin elderly non-diabetic patients hospitalized for pneumonian = 1,421
Wearable sweat sensor predicts glucose in humans (postprandial metabolic status of healthy participants).
“Finally, we evaluated the postprandial metabolic status of healthy participants to validate the wearable system for continuous real-time on-body monitoring”
Human trialpostprandial metabolic status of healthy participants
Higher plasma glucose is associated with a larger brain age gap in human observational research; glucose also tracks cardiovascular age in people without self-reported diabetes. Human trials report glucose reductions with exercise, ketone drinks, and fasting-mimicking diets, while time-restricted feeding and resveratrol trials report both reductions and no clear effect.
Glucose is associated with brain age gap in human observational research and lifespan in a comparative bird preprint, where the association plateaus. Human trials report lower glucose with ketone drinks and fasting-mimicking diets, but reductions or no change with time-restricted feeding and resveratrol.
A human study links higher plasma glucose to a larger brain age gap; a bird-species preprint reports a glucose–lifespan association that plateaus. A study in female mice links lower glucose to greater frailty. Human trials report glucose reductions with fasting-mimicking diets and acarbose, but acarbose has no effect after intravenous glucose.
Summary rewritten as its findings changed.
As it read before
Glucose is associated with retinal and brain age gaps in human studies and with lifespan across bird species, where the association plateaus. A human trial reports lower glucose after exercise in sedentary older women with sarcopenic obesity; cognitive results differ, with impaired working memory in female C. aethiops but a positive association with cognitive function in foreign-born Latinos.
Summary rewritten as its findings changed.
As it read before
Reviews describe contrasting glucose responses in humans: no effect of combined aerobic and resistance exercise in women with breast cancer, but reductions with exercise using high-frequency interruption strategies.
A systematic analysis covering 204 countries and territories found broadly stable rates after accounting for age, but projected growing burden concentrated at ages 70 and…A systematic analysis covering 204 countries and territories found broadly stable rates after accounting for age, but projected growing burden concentrated at ages 70 and older.